Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Sweden
Biotech
Guard argues new data render primary endpoint miss 'irrelevant'
Guard branded its failure on the primary kidney injury endpoint “irrelevant," arguing longer-term assessments show its asset has a future.
Nick Paul Taylor
Sep 19, 2023 9:35am
BC Platforms acquires CRO 4Pharma for undisclosed price
Jun 14, 2023 4:05pm
Eir raises $138M fund to fill gap in Nordic life science scene
Dec 9, 2021 3:00am
Charles River dumps research model site, Swedish CDMO for $115M
Oct 13, 2021 3:20pm
Drones airdrop defibrillators to heart attack patients
Aug 26, 2021 6:05pm
Stopping cancer cells by blocking a growth-promoting protein
Aug 9, 2021 10:00am
